Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,075.00
+35.00 (0.87%)
At close: Jan 23, 2026
14.63%
Market Cap62.46B
Revenue (ttm)205.21B
Net Income (ttm)-1.37B
Shares Out15.33M
EPS (ttm)-91.41
PE Ration/a
Forward PEn/a
Dividend75.00 (1.76%)
Ex-Dividend DateDec 29, 2025
Volume151,452
Average Volume866,233
Open4,010.00
Previous Close4,040.00
Day's Range3,955.00 - 4,080.00
52-Week Range3,400.00 - 6,130.00
Beta0.49
RSI46.80
Earnings Daten/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements